224 related articles for article (PubMed ID: 31881026)
1. The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.
Wu CY; Chiu HY; Tsai TF
PLoS One; 2019; 14(12):e0225112. PubMed ID: 31881026
[TBL] [Abstract][Full Text] [Related]
2. Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.
Hsiao CY; Chiu HY; Wang TS; Tsai TF
PLoS One; 2017; 12(9):e0184178. PubMed ID: 28886099
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serial QuantiFERON-TB Gold in tube test results and tuberculosis infection status in patients with psoriasis receiving anti-IL-17 treatment (secukinumab and ixekizumab): Real-world data from a tuberculosis-endemic country.
Erbağcı E; Koç Yıldırım S; Hapa FA
Australas J Dermatol; 2024 Jul; ():. PubMed ID: 38946637
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
[TBL] [Abstract][Full Text] [Related]
5. Serial Quantiferon-TB Gold test results in 279 patients with psoriasis receiving biologic therapy.
Akdogan N; Dogan S; Gulseren D; Yalici-Armagan B; Ersoy-Evans S; Elcin G; Karaduman A; Atakan N
Dermatol Ther; 2021 Jan; 34(1):e14699. PubMed ID: 33368959
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.
Chiu HY; Hsueh PR; Tsai TF
Br J Dermatol; 2011 Mar; 164(3):553-9. PubMed ID: 21083541
[TBL] [Abstract][Full Text] [Related]
7. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results.
Seyhoglu E; Uyaroğlu OA; Erden A; Kilic L; Karadag O; Akdogan A; Bilgen SA; Ertenli I; Kiraz S; Kalyoncu U
Clin Rheumatol; 2021 May; 40(5):2027-2035. PubMed ID: 33057917
[TBL] [Abstract][Full Text] [Related]
8. Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis.
Elewski BE; Baddley JW; Deodhar AA; Magrey M; Rich PA; Soriano ER; Soung J; Bao W; Keininger D; Marfo K; Patekar M; Sharma A; Shete A; Lebwohl MG
JAMA Dermatol; 2021 Jan; 157(1):43-51. PubMed ID: 33001147
[TBL] [Abstract][Full Text] [Related]
9. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
10. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of
Xu Y; Yang Q; Zhou J; Zhou F; Hezhang Y; Gao Y; Shao L; Shi J; Ruan Q; Zhang W
Microbiol Spectr; 2022 Apr; 10(2):e0187021. PubMed ID: 35234509
[TBL] [Abstract][Full Text] [Related]
11. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
[TBL] [Abstract][Full Text] [Related]
13. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
Chandrasekaran P; Mave V; Thiruvengadam K; Gupte N; Shivakumar SVBY; Hanna LE; Kulkarni V; Kadam D; Dhanasekaran K; Paradkar M; Thomas B; Kohli R; Dolla C; Bharadwaj R; Sivaramakrishnan GN; Pradhan N; Gupte A; Murali L; Valvi C; Swaminathan S; Gupta A;
PLoS One; 2018; 13(8):e0199360. PubMed ID: 30067752
[TBL] [Abstract][Full Text] [Related]
14. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic.
Shah M; DiPietro D; Greenbaum A; Ketemepi S; Martins-Evora M; Marsiglia V; Dorman SE
PLoS One; 2012; 7(5):e36551. PubMed ID: 22586476
[TBL] [Abstract][Full Text] [Related]
15. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
[TBL] [Abstract][Full Text] [Related]
16. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
[TBL] [Abstract][Full Text] [Related]
17. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
Matsumoto T; Yamazaki T
Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
[TBL] [Abstract][Full Text] [Related]
18. The QuantiFERON-TB Gold In-Tube Assay in Neuro-Ophthalmology.
Little LM; Rigi M; Suleiman A; Smith SV; Graviss EA; Foroozan R; Lee AG
J Neuroophthalmol; 2017 Sep; 37(3):242-246. PubMed ID: 28079759
[TBL] [Abstract][Full Text] [Related]
19. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
[TBL] [Abstract][Full Text] [Related]
20. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
